Home > Insider Trading > Filing (0001214659-21-006640)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1293310	Humanigen Inc	HGEN	Pharmaceutical Preparations (2834)	770557236

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1421882	Cameron Durrant	C/O Humanigen, Inc. 533 Airport Boulevard, Suite 400 Burlingame CA 94010	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-03-01	111,441	$0.00	0	No	5	G	Direct
Common Stock	Acquisiton	2021-03-01	111,441	$0.00	111,441	No	5	G	Indirect	By Cameron Durrant Revocable Trust
Common Stock	Disposition	2021-06-14	26,441	$20.60	85,000	No	4	S	Indirect	By Cameron Durrant Revocable Trust
Common Stock	Disposition	2021-06-14	5,094	$21.14	79,906	No	4	S	Indirect	By Cameron Durrant Revocable Trust
Common Stock	Disposition	2021-06-14	49,906	$20.61	30,000	No	4	S	Indirect	By Cameron Durrant Revocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Direct
No	5	G	Indirect	By Cameron Durrant Revocable Trust
No	4	S	Indirect	By Cameron Durrant Revocable Trust
No	4	S	Indirect	By Cameron Durrant Revocable Trust
No	4	S	Indirect	By Cameron Durrant Revocable Trust

Footnotes

On March 1, 2021, the reporting person transferred 111,441 directly owned shares of the Company's common stock to the Cameron Durrant Revocable Trust (the "Trust"), of which the reporting person and his spouse are trustees and the reporting person's spouse is the primary beneficiary.
On June 14, 2021, the Trust sold an aggregate of 81,441 shares of the Company's common stock. The shares sold by the Trust represented approximately 3% of the reporting person's total ownership position in the Company (taking into account all of the reporting person's options to purchase shares of the Company's common stock).